Clinical Trial Update: Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating autologous stem cell collection and reinfusion in newly diagnosed high-grade gliomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Brainstem Glioma
• Ependymoma
• Mixed Glioma
• Oligodendroglioma
• Optic Nerve Glioma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Astrocytoma, Brainstem Glioma | EARLY_Phase 1 | Status: WITHDRAWN